中华航海医学与高气压医学杂志
中華航海醫學與高氣壓醫學雜誌
중화항해의학여고기압의학잡지
CHINESE JOURNAL OF NAUTICAL MEDICINE AND HYPERBARIC MEDICINE
2010年
1期
33-34
,共2页
宋仁兴%王寿先%王增武%王喆%王道奎%李圣君%靳世刚%张振兴
宋仁興%王壽先%王增武%王喆%王道奎%李聖君%靳世剛%張振興
송인흥%왕수선%왕증무%왕철%왕도규%리골군%근세강%장진흥
蛛网膜下腔出血%迟发性脑血管痉挛%高压氧
蛛網膜下腔齣血%遲髮性腦血管痙攣%高壓氧
주망막하강출혈%지발성뇌혈관경련%고압양
Subarachnoid hemorrhage%Delayed cerebral vasospasm%Hyperbaric oxygen
目的 探讨高压氧对蛛网膜下腔出血后迟发性脑血管痉挛的疗效.方法 回顾性分析2006年3月至2008年10月在我院治疗的42例动脉瘤蛛网膜下腔出血患者,高压氧组(21例)在常规治疗脑血管痉挛基础上辅以高压氧治疗,对照组(21例)采用常规方法治疗脑血管痉挛,对2组的临床疗效进行比较.结果 高压氧组迟发性脑血管痉挛的发生率为14.3%,脑梗死发生率为4.8%;对照组迟发性脑血管痉挛的发生率为47.6%,脑梗死发生率为23.8%.高压氧组迟发性脑血管痉挛和脑梗死发生率均较对照组低,2组比较差异有统计学意义(P<0.05).结论 高压氧治疗对蛛网膜下腔出血迟发性脑血管痉挛有一定的效果.
目的 探討高壓氧對蛛網膜下腔齣血後遲髮性腦血管痙攣的療效.方法 迴顧性分析2006年3月至2008年10月在我院治療的42例動脈瘤蛛網膜下腔齣血患者,高壓氧組(21例)在常規治療腦血管痙攣基礎上輔以高壓氧治療,對照組(21例)採用常規方法治療腦血管痙攣,對2組的臨床療效進行比較.結果 高壓氧組遲髮性腦血管痙攣的髮生率為14.3%,腦梗死髮生率為4.8%;對照組遲髮性腦血管痙攣的髮生率為47.6%,腦梗死髮生率為23.8%.高壓氧組遲髮性腦血管痙攣和腦梗死髮生率均較對照組低,2組比較差異有統計學意義(P<0.05).結論 高壓氧治療對蛛網膜下腔齣血遲髮性腦血管痙攣有一定的效果.
목적 탐토고압양대주망막하강출혈후지발성뇌혈관경련적료효.방법 회고성분석2006년3월지2008년10월재아원치료적42례동맥류주망막하강출혈환자,고압양조(21례)재상규치료뇌혈관경련기출상보이고압양치료,대조조(21례)채용상규방법치료뇌혈관경련,대2조적림상료효진행비교.결과 고압양조지발성뇌혈관경련적발생솔위14.3%,뇌경사발생솔위4.8%;대조조지발성뇌혈관경련적발생솔위47.6%,뇌경사발생솔위23.8%.고압양조지발성뇌혈관경련화뇌경사발생솔균교대조조저,2조비교차이유통계학의의(P<0.05).결론 고압양치료대주망막하강출혈지발성뇌혈관경련유일정적효과.
Objective To evaluate the therapeutic efficacy of hyperbaric oxygen on delayed cerebrovasacular spasm (DCVS) after subarachnoid hemorrhage. Methods Forty two patients with subarachnoid hemorrhage were randomly divided into HBO treatment group(21 cases) and control group(21 cases). The two groups were given the same treatment at first, and the HBO group was given HBO treatment additionally. Effect of therapy in the two groups were observed and compared. Results The incidence of DCVS was 14.3% in the HBO group and was 47.6% in the control group. There was significant difference in the rate of DCVS between the 2 groups (P < 0.05), the incidence of cerebral infarction was 4.8% in patients treated with HBO and was 23.8% in the control group. There was significant difference in the rate of cerebral infarction between the 2 group (P < 0.05). Conclusions HBO might be a valuable agent for the treatment of DCVS after subarachnoid hemorrhage.